Date: December 12, 2012 3:30-5:30pm
Presenters: Steven M. Ferguson, CLP, Deputy Director, Licensing and Entrepreneurship, NIH Office of Technology Transfer and Mark Rohrbaugh, J.D., Ph.D., Director NIH Office of Technology Transfer
Come hear the story behind the NIH Office of Technology Transfer winning the 2012 Deals of Distinction™ Award, one of the most prestigious for technology transfer that was just presented to NIH by the Licensing Executive Society on October 17th at their Annual Meeting in Toronto, Canada. The award was given to NIH along with the University of Illinois at Chicago and Gilead Sciences for license agreements granted to the Medicines Patent Pool, a newly established initiative of UNITAID, an international organization established to grant licenses for the generic manufacture and purchase of drugs against HIV/AIDS, malaria, and tuberculosis. In making the award the Licensing Executives Society cited this model partnership as “an innovative endeavor in facilitating access to HIV treatment in developing countries” and one that “showcases the success of public-private partnerships to improve availability of medicine”.